中国卒中杂志2025，Vol.20Issue(5)：529-548,20.DOI:10.3969/j.issn.1673-5765.2025.05.002
改变指南的力量——近20年中国缺血性脑血管病重磅临床研究
The Power of Changing Guidelines:Two Decades of Key Clinical Trials on Ischemic Cerebrovascular Disease in China
摘要
Abstract
Over the past two decades,China has made remarkable strides in clinical research on cerebrovascular disease,gradually shifting from relying on foreign research achievements to an international research model led by Chinese researchers.The CHANCE study marks the starting point of this progress,and with the introduction of other landmark studies,China has increasingly gained prominence in the global cerebrovascular disease research community.A series of key Chinese clinical studies have directly revised both national and international cerebrovascular disease guidelines.This article reviews the important clinical studies on ischemic cerebrovascular disease in China over the past two decades,explores the evidence-based basis for changing guidelines,and discusses future research directions,aiming to further advance the high-quality development of clinical research on ischemic cerebrovascular disease in China.关键词
缺血性脑血管病/临床研究/指南/中国Key words
Ischemic cerebrovascular disease/Clinical research/Guideline/China分类
医药卫生引用本文复制引用
谭泽锋,徐安定..改变指南的力量——近20年中国缺血性脑血管病重磅临床研究[J].中国卒中杂志,2025,20(5):529-548,20.基金项目
广东省自然科学基金(2023A1515010241) （2023A1515010241）
